- €194.92m
- €261.43m
- €95.21m
- 53
- 75
- 75
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 64.1 | 74.3 | 97.1 | 93.5 | 95.2 |
Cost of Revenue | |||||
Gross Profit | 58.9 | 68.1 | 90.4 | 87 | 87.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 49.8 | 56.7 | 67.8 | 69.4 | 71.6 |
Operating Profit | 14.2 | 17.6 | 29.3 | 24.1 | 23.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13.7 | 17.6 | 29.2 | 24 | 23.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.5 | 12.9 | 22.1 | 17.3 | 16.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 9.5 | 12.3 | 21.5 | 15.2 | 16.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.5 | 12.3 | 21.5 | 15.2 | 16.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.21 | 0.28 | 0.47 | 0.324 | 0.333 |
Dividends per Share | |||||
Special Dividends per Share |